CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
About this item
Full title
Author / Creator
Marofi, Faroogh , Saleh, Marwan Mahmood , Rahman, Heshu Sulaiman , Suksatan, Wanich , Al-Gazally, Moaed E , Abdelbasset, Walid Kamal , Thangavelu, Lakshmi , Yumashev, Alexei Valerievich , Hassanzadeh, Ali , Yazdanifar, Mahboubeh , Motavalli, Roza , Pathak, Yashwant , Naimi, Adel , Baradaran, Behzad , Nikoo, Marzieh and Khiavi, Farhad Motavalli
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Adoptive cell therapy has received a great deal of interest in the treatment of advanced cancers that are resistant to traditional therapy. The tremendous success of chimeric antigen receptor (CAR)-engineered T (CAR-T) cells in the treatment of cancer, especially hematological cancers, has exposed CAR’s potential. However, the toxicity and signific...
Alternative Titles
Full title
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
Authors, Artists and Contributors
Author / Creator
Saleh, Marwan Mahmood
Rahman, Heshu Sulaiman
Suksatan, Wanich
Al-Gazally, Moaed E
Abdelbasset, Walid Kamal
Thangavelu, Lakshmi
Yumashev, Alexei Valerievich
Hassanzadeh, Ali
Yazdanifar, Mahboubeh
Motavalli, Roza
Pathak, Yashwant
Naimi, Adel
Baradaran, Behzad
Nikoo, Marzieh
Khiavi, Farhad Motavalli
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_721f0f118fda4207b1d88085375da769
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_721f0f118fda4207b1d88085375da769
Other Identifiers
ISSN
1757-6512
E-ISSN
1757-6512
DOI
10.1186/s13287-021-02462-y
